Target intelligence / Profile preview

Daboia russelii siamensis Kunitz-type serine protease inhibitor (DrS-Kunitz)

Target
DrS-Kunitz
Molecular classification
Kunitz-type protease inhibitor, Serine protease inhibitor, Venom toxin
01

Overview

Daboia russelii siamensis Kunitz-type serine protease inhibitor toxins are a group of small proteins (approximately 6-7 kDa) found in the venom of the Eastern Russell's Viper (Daboia siamensis). These toxins possess a characteristic Kunitz fold stabilized by three conserved disulfide bonds, which allows them to function as potent competitive inhibitors of various serine proteases, such as trypsin and chymotrypsin (UniProt P00991). In the context of human envenomation, these inhibitors interfere with the delicate balance of the coagulation and fibrinolytic cascades, contributing to the severe systemic symptoms of Russell's viper bites, including viper-induced consumptive coagulopathy (VICC) and spontaneous hemorrhage (Journal of Proteomics, 2014). While they are primarily viewed as toxic agents, they are the specific targets of therapeutic antivenoms, which utilize polyclonal antibodies to sequester and neutralize the toxins in the bloodstream. Beyond their role in pathology, these Kunitz-type inhibitors are valuable in biochemical research and drug discovery as scaffolds for developing highly specific protease inhibitors for treating conditions like thrombosis or excessive inflammation (Toxins, 2018).

Other names
Daboia siamensis Kunitz-type inhibitorEastern Russell's viper Kunitz-type protease inhibitorVipera russelli protease inhibitorKunitz-type venom basic protease inhibitorDrKIn
02

Mechanism of action

Neutralization by antivenom antibodies which bind to the toxin's active site or surface epitopes, sterically hindering its interaction with host serine proteases and preventing the inhibition of endogenous coagulation factors.

03

Biological functions

Serine protease inhibitionNegative regulation of endopeptidase activityInterference with blood coagulationNegative regulation of fibrinolysis
04

Disease associations

Snakebite envenomationCoagulopathyHemorrhageViper-induced consumptive coagulopathy (VICC)
05

Safety considerations

Systemic toxicityRapid onset of coagulopathyPotential for anaphylaxis or serum sickness following antivenom administrationAcute kidney injury secondary to envenomation
06

Interacting drugs

Russell's Viper Antivenin (Thai Red Cross Society)

1 more in the full profile.

07

Biomarkers

Prothrombin time (PT)Activated partial thromboplastin time (aPTT)Fibrinogen levelsVenom antigen levels (ELISA)

Beyond the preview

Go deeper on Daboia russelii siamensis Kunitz-type serine protease inhibitor (DrS-Kunitz).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia russelii siamensis Kunitz-type serine protease inhibitor (DrS-Kunitz).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call